SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                 SCHEDULE 13D/A

                    UNDER THE SECURITIES EXCHANGE ACT OF 1934


                           APPLIED DNA SCIENCES, INC.
     -----------------------------------------------------------------------
                                (Name of Issuer)

                         COMMON STOCK, PAR VALUE $0.0001
     -----------------------------------------------------------------------
                         (Title of Class of Securities)

                                   03815U 10 2
         --------------------------------------------------------------
                                 (CUSIP Number)


RHL MANAGEMENT, INC. 8233 ROXBURY ROAD, LOS ANGELES CA   90069
- -------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
                                 Communications)

                                 August 28, 2003
         --------------------------------------------------------------
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously  filed a statement on Schedule 13G to report
the  acquisition  that is the subject of this  Schedule  13D, and is filing this
schedule  because of Rule 13d-1(e),  Rule 13d-1(f) or Rule  13d-1(g),  check the
following box [].

Note:  Schedules  filed in paper format shall include a signed original and five
copies of the  schedule,  including  all  exhibits.  See Rule 13d-7(b) for other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for  any  subsequent   amendment   containing   information  which  would  alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the  Securities  Exchange  Act of
1934 ("Act") or otherwise  subject to the liabilities of that section of the Act
but  shall be  subject  to all other  provisions  of the Act  (however,  see the
Notes).


CUSIP NO.
03815U 10 2



                                  SCHEDULE 13D

- ----------------------------                            -----------------
CUSIP NO. 03815U 10 2                                   PAGE 2 OF 5 PAGES
- ----------------------------                            -----------------


- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
   S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     RHL Management, Inc.                   n/a
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
                                        (A) [ ]
                                        (B) [ ]

- --------------------------------------------------------------------------------
3  SEC USE ONLY


- --------------------------------------------------------------------------------
4  SOURCE OF FUNDS (See Instructions)

   OO
- --------------------------------------------------------------------------------
5  CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
   ITEM  2(d) or 2(e)

- --------------------------------------------------------------------------------
6    CITIZENSHIP OR PLACE OF ORGANIZATION
     U.S.A.

- --------------------------------------------------------------------------------
7     SOLE VOTING POWER

                      400,000
 NUMBER OF    -----------------------------------------------------------------
    SHARES      8     SHARED VOTING POWER
 BENEFICIALLY
   OWNED BY              - 0 -
     EACH       ---------------------------------------------------------------
   REPORTING    9     SOLE DISPOSITIVE POWER
    PERSON
     WITH               400,000
                ---------------------------------------------------------------
                10    SHARED DISPOSITIVE POWER

                      - 0 -
- --------------------------------------------------------------------------------
11     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

       400,000
- --------------------------------------------------------------------------------

12     CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
       SHARES        (See Instructions) [ ]
- --------------------------------------------------------------------------------
13     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

       2.37%
- --------------------------------------------------------------------------------
14     TYPE OF REPORTING PERSON (See Instructions)

       CO
- --------------------------------------------------------------------------------



                                                               -----------------
                                                               PAGE 3 OF 5 PAGES
                                                               -----------------


ITEM 1. SECURITY AND ISSUER.

This  Statement  relates to shares of common stock,  $0.0001 par value per share
(the "Common Stock"),  of APPLIED DNA SCIENCES,  INC. (the  "Corporation").  The
Corporation's  principal  executive  office is located at 8233 Roxbury Road, Los
Angeles, CA 90069


ITEM 2. IDENTITY AND BACKGROUND.

(a) This  Statement  is being  filed by RHL  Management,  Inc.  (the  "Reporting
Person").

(b) The business address of the Reporting Person is:

8233 Roxbury Road
Los Angeles CA 90069

(c) The Reporting Person's present principal occupation is:

         International Business Consultant.

(d) Mr.  Langley is the President and majority  shareholder  of RHL  Management,
Inc. During the last five years, RHL Management,  Inc. has not been convicted in
a criminal proceeding.

(e) During the last five years, Richard H. Langley, Jr. pled guilty to one count
of conspiracy to commit wire fraud in connection with a plea bargain. During the
last five years, RHL Management, Inc. has not been a party to a civil proceeding
of a judicial or administrative  body of competent  jurisdiction and as a result
of such proceeding  been subject to a judgment,  decree or final order enjoining
future violations of, or prohibiting or mandating activities subject to, federal
or state securities law or finding any violation with respect to such law.

In  connection  with a public  administrative  proceeding  on October 10,  1996,
instituted  against  Richard H.  Langley Jr. and Gerald  Larder,  on October 10,
2000, the Securities and Exchange Commission accepted





                                                               -----------------
                                                               PAGE 4 OF 5 PAGES
                                                               -----------------

Offers of Settlement whereby the Commission  ordered:  (i) sanctions imposed and
issued  cease-and-desist  orders  against the  respondents  from  committing and
causing  any  violations  and any  future  violations  of  Section  17(a) of the
Securities  Act and Section 10(b) of the Exchange Act; (ii)  respondents  barred
from  participation  in penny stock  offerings;  and (iii)  disgorgement  in the
amount of $2,224.55,plus interest.

(f) The Reporting Person is a Nevada corporation.

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

On August 28, 2003,  2003, the Reporting  Person sold 4,920,000 shares of common
stock of the Company to Lawrence Lee, the President of the Company, in a private
transaction  for a purchase price of Five Million  Dollars  ($5,000,000),  which
purchase price is to be paid as follows:  (i) Fifty Thousand Dollars  ($50,000),
was paid by certified  check from personal  funds at the time of transfer of the
Stock; (ii) Fifty Thousand Dollars is to be paid within 60 days of the execution
of the stock  purchase  agreement;  and (iii) the balance of Four  Million  Nine
Hundred  Thousand  Dollars  ($4,900,000)  is to be paid pursuant to a promissory
note.

By way of background,  the Reporting Person originally acquired shares of Common
Stock of the  Company in a Plan and  Agreement  of  Reorganization  between  the
shareholders  of Applied DNA Sciences,  Inc. (of which the reporting  entity was
one of two) and ProHealth Medical  Technologies,  Inc. After the reorganization,
ProHealth  Medical  Technologies,  Inc. was renamed  Applied DNA Sciences,  Inc.
Subsequently,  in March of  2003,  the  Reporting  Person  entered  into a stock
purchase agreement with O'Dwyer Management,  Inc., a Florida corporation,  which
transaction  was  rescinded  on August 27, 2003. A 13D was filed to disclose the
rescission.


ITEM 4. PURPOSE OF TRANSACTION.



The Reporting  Person entered into a stock  purchase  agreement in March of 2003
with O'Dwyer Management, Inc. which was rescinded August 27, 2003. The reporting
person does not have any present plan or proposal as a stockholder which relates
to, or would  result in any  action  with  respect  to,  the  matters  listed in
paragraphs  (b) through (j) of Item 4 of Schedule 13D. This report  reflects the
Reporting Person's sale of 4,920,000 shares of Common Stock.


ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

(a) As of August 27, 2003, the corporation had issued and outstanding a total of
16,874,660 shares of Common Stock. As of that date, the Reporting Person was the
beneficial  owner of 400,000  shares of Common  Stock or 2.37% of the issued and
outstanding Common Stock.

(b) The Reporting Person has the sole power to vote, or to direct 400,000 shares
of Common  Stock and sole power to dispose of, or to direct the  disposition  of
400,000 shares of Common Stock.

(c) The  Reporting  Person  initially  acquired  5,500,000  shares in a Plan and
Agreement of  Reorganization  under Section 368 (a)(1)B of the Internal  Revenue
Code  between the  shareholders  of Applied DNA  Sciences,  Inc.  and  ProHealth
Medical Technologies, Inc. (the former name of the reporting Nevada corporation,
Applied DNA Sciences, Inc.)

(d) Not applicable.

(e) Not applicable.

ITEM 6. CONTRACTS,  ARRANGEMENTS,  UNDERSTANDINGS  OR RELATIONSHIPS  WITH
        RESPECT TO SECURITIES OF THE ISSUER.

These  4,920,000  shares were sold to Lawrence Lee pursuant to a Stock  Purchase
Agreement  dated August 28, 2003, for a purchase  price of Five Million  Dollars
($5,000,000),  which purchase price is to be paid as follows: (i) Fifty Thousand
Dollars  ($50,000),  was paid by certified check from personal funds at the time
of transfer of the Stock;  (ii) Fifty  Thousand  Dollars is to be paid within 60
days of the execution of the stock  purchase  agreement;  and (iii) Four Million
Nine  Hundred  Thousand  Dollars  ($4,900,000)  is  to  be  paid  pursuant  to a
three-year  promissory note bearing interest at a rate of 5% per annum. Lawrence
Lee's obligations under the promissory note are secured by a pledge of the stock
sold and by a [Mortgage] on certain real property owned by Lawrence Lee.

Richard  H.  Langley,  Jr.,  the  President  and  majority  shareholder  of  RHL
Management,  Inc.,  previously  had a  consulting  agreement  with the Issuer to
provide International Business Development and Advisory services.


ITEM 7.     MATERIAL TO BE FILED AS EXHIBITS.

n/a




SIGNATURE.

After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.

Dated: August 28, 2003


                                    RHL Management, Inc.

                                    /s/  Rick Langley
                                    --------------------------
                                    By: Richard H. Langley